
Associate Scientific Director, Medical Communications
Precision AQ
Boston, MA (Remote)
USA (Remote)
Posted 3 months ago
The other 99% submit and hope. You're about to do something different.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Position Overview
Kyverna is seeking an experienced and strategic Associate Director, Medical Communications, to lead the development and execution of a comprehensive, publication-focused scientific communications strategy. This role is responsible for shaping and delivering high-impact scientific communications across peer-reviewed journals, medical congresses, and broader external channels.
The Associate Director will drive the end-to-end publication lifecycle, including publication planning, authorship strategy, content development, and execution excellence. This individual will serve as a key leader within Medical Affairs, translating complex clinical and scientific data into clear, credible narratives while ensuring full compliance with Good Publication Practice (GPP), ICMJE guidelines, and internal standards. This role requires both strategic leadership and hands-on execution, with responsibility for guiding cross-functional teams and external partners to ensure timely, high-quality, and compliant dissemination of data aligned with Kyverna’s scientific and Medical Affairs objectives.
Department: Medical Affairs
Location: Remote eligible
Reports To: Director, Medical Affairs
Travel: Willingness to travel up to approximately 20%
The national salary range for this position is from $170,000 to $190,000 USD annually. This salary range is an estimate of what we reasonably expect to pay for this posted position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock plan.
Kyverna is a clinical-stage biopharmaceutical company focused on liberating autoimmune patients through the curative potential of cell therapy. Kyverna’s lead autologous CD19-targeting CAR T-cell therapy candidate, miv-cel (mivocabtagene autoleucel, KYV-101), has demonstrated the potential to fundamentally change the treatment paradigm across multiple B-cell-driven autoimmune diseases.Kyverna is advancing its potentially first-in-class neuroimmunology franchise with its recently completed registrational trial in stiff person syndrome and an ongoing registrational trial for generalized myasthenia gravis. The Company is also harnessing other KYSA trials and investigator-initiated trials, including in multiple sclerosis and rheumatoid arthritis, to inform the next priority indications. Additionally, its next generation pipeline includes CAR T-cell therapies deploying novel innovations to improve patient access and experience.

Precision AQ
Boston, MA (Remote)

Columbia University Irving Medical Center
New York, USA (On-site)

Medical College of Wisconsin
Wauwatosa, WI (On-site)